🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Milad Sharifpour

Cedars-Sinai Medical Center

ORCID: 0000-0003-4507-0849

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial”.

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(21)00751-9

N/A

6.2DataRank · unranked

194 citations

Uriel Sandkovsky, Cavan S. Reilly, David M. Vock, Robert L. Gottlieb, Michael Mack +95 more

C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19

PLoS ONE(2020)10.1371/journal.pone.0242400

N/A

0DataRank · unranked

146 citations

Srikant Rangaraju, Michael Liu, Darwish Alabyad, Fadi Nahab, Christina Creel-Bulos +2 more

Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019

Medicine(2020)10.1097/md.0000000000023186

N/A

0DataRank · unranked

31 citations

Michael Liu, Sara C. Auld, Manila Gaddh, Christine L. Kempton, Milad Sharifpour +5 more